Literature DB >> 1398961

Some properties of purified Escherichia coli heat-stable enterotoxin II.

S Hitotsubashi1, Y Fujii, H Yamanaka, K Okamoto.   

Abstract

We examined the biological properties of purified Escherichia coli heat-stable enterotoxin II (STII) using mouse intestinal loop assays and compared these properties with those of heat-stable enterotoxin I (STI) and cholera toxin (CT). The action of STII over time differed from those of STI and CT. STII did not alter cyclic GMP or cyclic AMP levels in intestinal mucosal cells. Our results supported the idea that the mechanism of action of STII in inducing fluid secretion is different from the mechanisms of action of STI and CT. This hypothesis was further supported by the fact that an anti-STII neutralizing serum did not neutralize the activities of STI and CT. Subsequently, we examined the involvement of prostaglandins in the action of STII. The level of prostaglandin E2 in the fluid accumulated as a result of the action of STII increased, and the prostaglandin synthesis inhibitors aspirin and indomethacin significantly reduced the response to STII. These results implicate prostaglandin E2 in the mechanism of action of STII.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398961      PMCID: PMC258190          DOI: 10.1128/iai.60.11.4468-4474.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Human diarrheal disease caused by enterotoxigenic Escherichia coli.

Authors:  R B Sack
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

2.  The mechanism of action of cholera toxin in pigeon erythrocyte lysates.

Authors:  D M Gill; C A King
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

3.  Guanylyl cyclase is a heat-stable enterotoxin receptor.

Authors:  S Schulz; C K Green; P S Yuen; D L Garbers
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  Differential effects of prostaglandins in the mesenteric vascular bed.

Authors:  B M Chapnick; L P Feigen; A L Hyman; P J Kadowitz
Journal:  Am J Physiol       Date:  1978-09

7.  Purification and characterization of Escherichia coli heat-stable enterotoxin II.

Authors:  Y Fujii; M Hayashi; S Hitotsubashi; Y Fuke; H Yamanaka; K Okamoto
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

8.  Production and purification of heat-stable enterotoxin b from a porcine Escherichia coli strain.

Authors:  J D Dubreuil; J M Fairbrother; R Lallier; S Larivière
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Detection of cholera enterotoxin activity in suckling hamsters.

Authors:  T Takeda; Y Takeda; T Miwatani; N Ohtomo
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Glutamic acid-112 of the A subunit of heat-labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP-ribosyltransferase activity.

Authors:  T Tsuji; T Inoue; A Miyama; M Noda
Journal:  FEBS Lett       Date:  1991-10-21       Impact factor: 4.124

View more
  25 in total

1.  Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation.

Authors:  Benoit Chassaing; Estelle Garénaux; Jessica Carriere; Nathalie Rolhion; Yann Guérardel; Nicolas Barnich; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  J Bacteriol       Date:  2015-02-09       Impact factor: 3.490

2.  An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Authors:  Miho Watanabe-Takahashi; Toshio Sato; Taeko Dohi; Noriko Noguchi; Fumi Kano; Masayuki Murata; Takashi Hamabata; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

Review 3.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

4.  The σE pathway is involved in biofilm formation by Crohn's disease-associated adherent-invasive Escherichia coli.

Authors:  Benoit Chassaing; Arlette Darfeuille-Michaud
Journal:  J Bacteriol       Date:  2012-10-26       Impact factor: 3.490

5.  Interaction of Escherichia coli heat-stable enterotoxin B with cultured human intestinal epithelial cells.

Authors:  K L Chao; L A Dreyfus
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Effect of alterations of basic amino acid residues of Escherichia coli heat-stable enterotoxin II on enterotoxicity.

Authors:  Y Fujii; Y Okamuro; S Hitotsubashi; A Saito; N Akashi; K Okamoto
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Disulfide bond formation and secretion of Escherichia coli heat-stable enterotoxin II.

Authors:  K Okamoto; T Baba; H Yamanaka; N Akashi; Y Fujii
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

8.  Contribution of individual disulfide bonds to biological action of Escherichia coli heat-stable enterotoxin B.

Authors:  Y L Arriaga; B A Harville; L A Dreyfus
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Sulfatide from the pig jejunum brush border epithelial cell surface is involved in binding of Escherichia coli enterotoxin b.

Authors:  E Rousset; J Harel; J D Dubreuil
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Calcium influx mediated by the Escherichia coli heat-stable enterotoxin B (STB).

Authors:  L A Dreyfus; B Harville; D E Howard; R Shaban; D M Beatty; S J Morris
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.